ObjectiveWe aimed to perform a systematic review and meta‐analysis of myringoplasty outcomes following platelet concentrates application in patients with chronic otitis media (COM).Data SourcesWe searched MEDLINE, Embase, and Cochrane Central register of Controlled Clinical Trials (CENTRAL). We also performed a manual search in Google Scholar and reference lists.Review MethodsEligible for inclusion were randomized controlled trials on COM patients undergoing myringoplasty with platelet concentrates (platelet‐rich plasma or platelet‐rich fibrin) compared to myringoplasty alone. The primary outcomes were graft uptake and air‐bone gap (ABG) gain, while the secondary outcome was complication rate. We used odds ratio (OR) and standardized mean difference (SMD) to represent dichotomous and continuous outcomes, respectively.ResultsThirteen trials (n = 1179) were deemed eligible. Platelet concentrates significantly improved graft uptake after 6 months (OR: 2.45, 95% confidence interval [CI]: 1.34‐4.47, P = .004, I2 = 0%, high certainty), ABG gain (SMD: 0.36, 95% CI: 0.17‐0.55, P = .0002, I2 = 0%, moderate certainty), and complication rate (OR: 0.38, 95% CI: 0.18‐0.82, P = .01, I2 = 0%, low certainty).ConclusionOur results showed that platelet concentrates may improve graft uptake and ABG gain and reduce complications in COM patients undergoing myringoplasty. Caution is warranted given to the relatively small sample size, as well as inconsistent reporting across included trials.